CardiologyOnline.net

Cardiology Xagena

Xagena Mappa
Medical Meeting
Dermabase.it
Gastrobase.it

Search results for "Major adverse cardiovascular events"

In the most up-to-date analysis yet of this contentious issue, researchers from the University of Michigan Cardiovascular Center and the Blue Cross Blue Shield of Michigan Cardiovascular Consortium fi ...


Results from three early-phase, cross-over studies demonstrated that all subjects responded to Prasugrel ( Effient ), an investigational antiplatelet agent, while 22 to 43 percent of the same subjects ...


Researchers conducted the HIJ-CREATE ( The Heart Institute of Japan-Candesartan Randomized trial for Evaluation in Coronary Artery Disease ) trial to determine whether the angiotensin II receptor bloc ...


Resistant hypertension increases the risk of stroke by 35% in women and 20% in elderly Taiwanese patients, according to research presented at ESC Congress by Dr Kuo-Yang Wang from Taiwan. The findin ...


Two separate clinical trials were presented as a part of ACC.15, and looked at strategies to reduce major bleeding and mortality in patients with acute coronary syndrome ( ACS ). Both trials are part ...


Results from the phase 2b ixCELL-DCM clinical study of Ixmyelocel-T in patients with advanced heart failure due to ischemic dilated cardiomyopathy, were presented at the American College of Cardiology ...


Results from the global phase III CANTOS study investigating the efficacy, safety and tolerability of Canakinumab ( ACZ885 ) in combination with standard of care in people with a prior myocardial inf ...


In statin trials, men and women have shown similar relative risk reductions in cardiovascular events per 39 mg/dL low-density lipoprotein cholesterol ( LDL-C ) reduction. Researchers have assessed wh ...


Patients with chronic coronary artery disease ( CAD ) or peripheral artery disease ( PAD ) and history of heart failure ( HF ) are at high risk for major adverse cardiovascular events ( MACE ). Re ...


A large Cleveland Clinic study has shown that weight-loss surgery performed in patients with type 2 diabetes and obesity is associated with a lower risk of death and major adverse cardiovascular event ...